$27M mkt cap, $27M in cash. In historical support area.Trading at cash value (as of last financials). In historical support area. Active share buyback program. Good news flow. History of big bounces.
Shroom
Deeply oversold/undervalued psychedelics playPsychedelics space has seen some multi-baggers in the span of the last 2 weeks, suggesting investors are once again starting to pour money into speculative shroom stocks.
CSE:LVT is deeply oversold (RSI @ 22.69), hitting all time lows. The company is deeply fundamentally undervalued:
- $1.87M market cap
- Raised $1.5M at 0.20 in February
- Generating revenue of over $2M per quarter
Some comparable psychedelic companies with less revenue are trading at more than 10x. Unless there's some kind of fundamental/unknown reason for recent selloff, other than weak general markets, this is a potential multi-bagger candidate from current levels, in my humble opinion. GLTA